The impact of heparin coated circuits upon metabolism in vital organs: Effect upon cerebral and renal function during and after cardiopulmonary bypass

ASAIO Journal

Volumn 51, Issue 1, 2005, Pages 103-109

  De Vroege, Roel ^a   Stooker, Wim ^a   Van Oeveren, Wim ^b   Bakker, Edwin W M ^a   Huybregts, Rien A J M ^a   Van Klarenbosch, Jan ^a   Van Kamp, Gerard J ^a   Hack, C Erik ^c   Eijsman, Leon ^a   Wildevuur, Charles R H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; BRAIN; ENZYMES; GRAFTING (CHEMICAL); METABOLISM; NEUROLOGY; OXYGEN; PATIENT TREATMENT;

CARDIOPULMONARY BYPASS (CPB); CREATININE; HEPARIN; KIDNEYS;

CARDIOLOGY;

CREATININE; HEPARIN; N ACETYLGLUCOSAMINE; PROTAMINE; PROTEIN S100B; UREA;

ADULT; ARTICLE; BRAIN FUNCTION; CANNULATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; TISSUE PERFUSION; TREATMENT OUTCOME;

ACETYLGLUCOSAMINIDASE; AGED; ANTICOAGULANTS; BIOLOGICAL MARKERS; BRAIN; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; CREATININE; DOUBLE-BLIND METHOD; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARIN; HUMANS; INFLAMMATION; KIDNEY; MALE; MIDDLE AGED; OXYGEN; PATIENT SELECTION; S100 PROTEINS; UREA;

EID: 19944431244     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000151147.24915.49     Document Type: Article

References (34)

1. de Vroege R, van Oeveren W, van Klarenbosch J, et al: The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Anesth Analg 98: 1586-1594, 2004.
2. Yates SL, Alston RP: Neurological, psychological and cognitive sequalae of cardiac surgery. Curr Anaesth Crit Care 11: 187-93, 2000.
3. Bonventre JV, Weinberg JM: Recent advantages in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003.
4. Pepin E, Dulan S: Effects of mean arterial pressure on cerebral perfusion during cardiopulmonary bypass: A review. JECT 35: 297-303, 2003.
5. Parolari A, Alamanni F, Gherli T, et al: Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics. Ann Thorac Surg 67: 1320-1327, 1999.
6. Pinsky MR, Schlichtig R: Regional oxygen delivery in oxygen supply dependent states. Intensive Care Med 16 (Suppl.): 169-171, 1990.
7. Sungurtekin H, Boston US, Orszulak A, Cook DJ: Effect of cerebral embolization on regional autoregulation during cardiopulmonary bypass in dogs. Ann Thorac Surg 69: 1130-1134, 2000.
8. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR: Cardiopulmonary bypass induces leukocyte platelet adhesion. Blood 79: 1201-1205, 1992.
9. Brooker RF, Brown WR, Moody DM, et al: Cardiotomy suction: A major source of brain lipid e emboli during cardiopulmonary bypass. Ann Thorac Surg 65: 1651-1655, 1998.
10. Grocott HP, Croughwell ND, Amory DW, White WD, Kirchner JL, Newman MF: Cerebral emboli and serum S100β during cardiac operations. Ann Thorac Surg 65: 1645-1650, 1998.
11. Blauth C, Arnold J, Kohner EM, Taylor KM: Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet 11: 837-838, 1986.
12. Persson L, Hardemark HG, Gustafsson G, et al: S100 protein and neuron specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 18: 911-918, 1987.
13. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG: Determination of S100 and glial fibrillary acidic concentrations in cerebrospinal fluid after brain infarction. Stroke 22: 1254-1258, 1991.
14. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E: S-100 Protein in blood and urine during open heart surgery. Clin Chem 35: 1942-1944, 1989.
15. Pathi VL, Morrison J, MacPhaden A, Martin W, McQuiston AM, Wheatley DJ: Alterations in renal microcirculation during cardiopulmonary bypass. Ann Thorac Surg 65: 993-998, 1998.
16. Dance N, Price RG, Robinson D, Stirling JL: β-Galactosidase, β-glucosidase and N-acetyl-β-D-glucosaminidase in human kidney. Clin Chim Acta 24: 189-197, 1969.
17. Ruvolo G, Greco E, Speziale G, et al: Nitric oxide formation during cardiopulmonary bypass. Ann thorac Surg 57: 1055-1057, 1994.
18. Mehlhorn U, Krahwinkel A, Geissler HJ, et al: Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg 125: 178-183, 2003.
19. de Vroege R, Huybregts MAJM, van Oeveren W, et al: The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. Artif Organs (in press).
20. Shibata H, Yagi T: Rate assay of N-acetyl-β-D-hexosaminidase with 4-nitrophenyl N-acetyl-β-D-glucosaminidase as an artificial substrate. Clin Chim Acta 251: 53-64, 1996.
21. Tarentino AL, Maley F: β-N-Acetylglucosaminidase from hen oviduct. Methods Enzymol 28: 772-776, 1972.
22. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE: CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 157: 473-479, 1996.
23. Wolbink GJ, Bollen J, Baars JW, et al: Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for The quantification of complement activation via the classical pathway. J Immunol Methods 163: 67-76, 1993.
24. Mitchel BA. Optimal perfusion flow rates for cardiopulmonary bypass. J Extra-Corpor Technol 22: 165-183, 1991.
25. Gold JP, Charlson ME, Williams-Russo P, et al: Improvement of outcomes after coronary artery bypass. A randomized trial comparing intra-operative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 110: 1302-1311, 1995.
26. Hayashi Y, Sawa Y, Fukuyama N, Nakazawa H, Matsuda H: Inducible nitric oxide produc-tion is an adaptation to cardiopulmonary bypass-induced inflammatory response. Ann Thorac Surg 72: 149-155, 2001.
27. Blinman T, Maggard M: Rational manipulation of oxygen delivery. J Surg Res 92: 120-41, 2000.
28. Collard CD, Lekowski R, Jordan JE, Agah A, Stahl GL: Complement activation following oxidative stress. Mol Immunol 36: 941-948, 1999.
29. Straatsburg IH, Boermeester MA, Wolbink GJ, et al: Complement activation induced by ischemia-reperfusion in humans: A study in patients undergoing partial hepatectomy. J Hepatol 32: 783-791, 2000.
30. Lindsberg PJ, Ohman J, Letho T, et al: Complement activation in the central nervous system following blood brain barrier damage in man. Ann Neurol 40: 587-596, 1996.
31. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A: Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg 125: 1438-50, 2003.
32. Muth CM, Shank ES: Gas embolism. NEJM 342: 476-82, 2000.
33. Hulman G: The pathogenesis of fat embolism. J Pathology 179: 3-9, 1995.
34. Fearn SJ, Pole R, Wesnes K, Faragher EB, Hooper, TL, McCollum CN: Cerebral injury during cardiopulmonary bypass: Emboli impair memory. J Thorac Cardiovasc Surg 121: 1150-60, 2001.